RICH.BA
Healthcare Drug Manufacturers - Specialty & GenericLaboratorios Richmond S.A.C.I.F.
ARS 1,380.00
-130.00 -8.61% today
Price History
Not enough data
Key Stats
Market Cap
111.44B
Avg Volume
61
P/E (TTM)
8.63
EPS
ARS 175.64
52W High
ARS 2,215.00
52W Low
ARS 1,060.00
Div. Yield
0.0%
Valuation
P/B Ratio
1.04
P/S Ratio
1.07
EV/EBITDA
19.87
EV/Revenue
3.19
Margins
Gross Margin 62.0%
Operating Margin 2.9%
Net Margin 11.0%
EBITDA Margin 16.0%
Growth & Returns
Revenue Growth (YoY)
(13.6%)
Return on Equity
13.2%
Return on Assets
2.9%
Liquidity & Leverage
Current Ratio
0.92
Quick Ratio
0.49
Debt / Equity
2.05
Total Cash
3.87B
Total Debt
243.51B
About
Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company was incorporated in 1959 and is headquartered in Buenos Aires, Argentina.
www.richmondlab.com